FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 202 filers reported holding FIBROGEN INC in Q1 2021. The put-call ratio across all filers is 4.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $15,748,000 | +7.0% | 453,720 | +14.4% | 0.01% | -7.7% |
| Q4 2020 | $14,711,000 | -14.9% | 396,626 | -5.6% | 0.01% | -27.8% |
| Q3 2020 | $17,282,000 | +13.9% | 420,278 | +12.3% | 0.02% | 0.0% |
| Q2 2020 | $15,168,000 | +5.5% | 374,247 | -9.5% | 0.02% | -28.0% |
| Q1 2020 | $14,374,000 | -21.0% | 413,622 | -2.5% | 0.02% | +19.0% |
| Q4 2019 | $18,204,000 | +16.0% | 424,437 | +0.0% | 0.02% | -8.7% |
| Q3 2019 | $15,691,000 | -16.9% | 424,330 | +1.6% | 0.02% | +53.3% |
| Q2 2019 | $18,876,000 | +35.5% | 417,790 | +63.0% | 0.02% | -25.0% |
| Q1 2019 | $13,930,000 | +17.1% | 256,302 | -0.3% | 0.02% | +81.8% |
| Q4 2018 | $11,898,000 | -15.1% | 257,096 | +11.4% | 0.01% | -38.9% |
| Q3 2018 | $14,018,000 | -3.6% | 230,757 | -0.7% | 0.02% | -14.3% |
| Q2 2018 | $14,549,000 | +102.6% | 232,418 | +49.5% | 0.02% | +75.0% |
| Q1 2018 | $7,180,000 | – | 155,420 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |